» Articles » PMID: 22723710

Survival Motor Neuron Protein in Motor Neurons Determines Synaptic Integrity in Spinal Muscular Atrophy

Overview
Journal J Neurosci
Specialty Neurology
Date 2012 Jun 23
PMID 22723710
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

The inherited motor neuron disease spinal muscular atrophy (SMA) is caused by deficient expression of survival motor neuron (SMN) protein and results in severe muscle weakness. In SMA mice, synaptic dysfunction of both neuromuscular junctions (NMJs) and central sensorimotor synapses precedes motor neuron cell death. To address whether this synaptic dysfunction is due to SMN deficiency in motor neurons, muscle, or both, we generated three lines of conditional SMA mice with tissue-specific increases in SMN expression. All three lines of mice showed increased survival, weights, and improved motor behavior. While increased SMN expression in motor neurons prevented synaptic dysfunction at the NMJ and restored motor neuron somal synapses, increased SMN expression in muscle did not affect synaptic function although it did improve myofiber size. Together these data indicate that both peripheral and central synaptic integrity are dependent on motor neurons in SMA, but SMN may have variable roles in the maintenance of these different synapses. At the NMJ, it functions at the presynaptic terminal in a cell-autonomous fashion, but may be necessary for retrograde trophic signaling to presynaptic inputs onto motor neurons. Importantly, SMN also appears to function in muscle growth and/or maintenance independent of motor neurons. Our data suggest that SMN plays distinct roles in muscle, NMJs, and motor neuron somal synapses and that restored function of SMN at all three sites will be necessary for full recovery of muscle power.

Citing Articles

Motor pool selectivity of neuromuscular degeneration in type I spinal muscular atrophy is conserved between human and mouse.

Lee J, Chung W, Pisapia D, Henderson C Hum Mol Genet. 2024; 34(4):347-367.

PMID: 39690843 PMC: 11811418. DOI: 10.1093/hmg/ddae190.


IL-1ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology.

Allison R, Mangione C, Suneja M, Gawrys J, Melvin B, Belous N Mol Ther. 2024; 33(2):734-751.

PMID: 39673131 PMC: 11853362. DOI: 10.1016/j.ymthe.2024.12.016.


The () homeobox genes are conserved Hox targets involved in motor neuron development.

Catela C, Assimacopoulos S, Chen Y, Tsioras K, Feng W, Kratsios P bioRxiv. 2024; .

PMID: 38853975 PMC: 11160718. DOI: 10.1101/2024.05.30.596714.


Preemptive dual therapy for children at risk for infantile-onset spinal muscular atrophy.

Matesanz S, Brigatti K, Young M, Yum S, Strauss K Ann Clin Transl Neurol. 2024; 11(7):1868-1878.

PMID: 38817128 PMC: 11251472. DOI: 10.1002/acn3.52093.


Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy.

Hann S, Kim S, Kim Y, Jo Y, Kang J, Park H Elife. 2024; 12.

PMID: 38318851 PMC: 10945524. DOI: 10.7554/eLife.92731.


References
1.
Yamamoto M, Shook N, Kanisicak O, Yamamoto S, Wosczyna M, Camp J . A multifunctional reporter mouse line for Cre- and FLP-dependent lineage analysis. Genesis. 2009; 47(2):107-14. PMC: 8207679. DOI: 10.1002/dvg.20474. View

2.
Kariya S, Park G, Maeno-Hikichi Y, Leykekhman O, Lutz C, Arkovitz M . Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet. 2008; 17(16):2552-69. PMC: 2722888. DOI: 10.1093/hmg/ddn156. View

3.
Bosch-Marce M, Wee C, Martinez T, Lipkes C, Choe D, Kong L . Increased IGF-1 in muscle modulates the phenotype of severe SMA mice. Hum Mol Genet. 2011; 20(9):1844-53. PMC: 3071675. DOI: 10.1093/hmg/ddr067. View

4.
Park G, Kariya S, Monani U . Spinal muscular atrophy: new and emerging insights from model mice. Curr Neurol Neurosci Rep. 2010; 10(2):108-17. PMC: 2861773. DOI: 10.1007/s11910-010-0095-5. View

5.
Lutz C, Kariya S, Patruni S, Osborne M, Liu D, Henderson C . Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy. J Clin Invest. 2011; 121(8):3029-41. PMC: 3148744. DOI: 10.1172/JCI57291. View